BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29049198)

  • 21. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL; Fang JP; Tang RY; Chen XM
    BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer.
    Ou X; Gao G; Bazhabayi M; Zhang K; Liu F; Xiao X
    J Cancer Res Ther; 2019; 15(7):1597-1602. PubMed ID: 31939443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.
    Zhao Q; Xu WT; Shalieer T
    Dis Markers; 2016; 2016():2325987. PubMed ID: 27843173
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients.
    Zhang WJ; Wang XH; Gao ST; Chen C; Xu XY; Sun Q; Zhou ZH; Wu GZ; Yu Q; Xu G; Yao YZ; Guan WX
    J Surg Res; 2018 Feb; 222():93-101. PubMed ID: 29273380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
    Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
    Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer.
    Kozlowski M; Naumnik W; Niklinski J; Milewski R; Dziegielewski P; Laudanski J
    Neoplasma; 2011; 58(4):311-9. PubMed ID: 21520987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of E-cadherin expression in triple-negative breast cancer.
    Kashiwagi S; Yashiro M; Takashima T; Nomura S; Noda S; Kawajiri H; Ishikawa T; Wakasa K; Hirakawa K
    Br J Cancer; 2010 Jul; 103(2):249-55. PubMed ID: 20551954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and significance of molecular biomarkers in esophageal carcinoma in different nationalities patients in Xinjiang.
    Zhang L; Sun J; Zhang JQ; Yang M; Bai G; Ma XL
    Genet Mol Res; 2014 Jul; 13(3):5413-25. PubMed ID: 25078598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
    Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
    BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of epithelial cadherin in early gastric cancer and its correlation to lymph node micrometastasis and clinicopathologic features].
    Liu J; Cai JH; Yan QH; Wang FA; Song WQ; Zhou BJ; Masahide I
    Ai Zheng; 2007 May; 26(5):541-6. PubMed ID: 17672949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
    Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
    J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
    Qi RX; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.